Key result
Bilateral and partial chordo-papillary preservation during mitral valve replacement improved left ventricular ejection fraction at 6 months compared to complete excision.
Why the study?
Disruption of the mitral valve apparatus during mitral valve replacement has been postulated as a risk factor for postoperative ventricular dysfunction.
Does single or bilateral chordo-papillary apparatus preservation improve left ventricular function compared to no preservation in patients undergoing mitral valve replacement?
Observational (n=60)
Does single or bilateral chordo-papillary apparatus preservation improve left ventricular function compared to no preservation in patients undergoing mitral valve replacement?
Preservation of the chordo-papillary apparatus during mitral valve replacement significantly improves postoperative left ventricular function and reduces ICU and mechanical ventilation times compared to complete excision.
Answers are grounded in this paper and cite their sources.
Preservation of chordo-papillary apparatus was associated with better LVEF after MVR; leaves open whether randomized trials should change practice.
Background: It has been postulated that disruption of the mitral valve apparatus at the time of mitral valve replacement (MVR) is a risk factor for postoperative ventricular dysfunction. The aim of this study was to evaluate the effect of single versus bilateral chordo-papillary preservation on the left ventricular function in comparison to no preservation. Methods: This study was conducted from 2015 to 2018 on sixty patients who had MVR. The patients were classified into group I included 20 patients who underwent MVR with complete excision of the subvalvular chordae and tips of papillary muscles, group II: included 20 patients who underwent MVR with preservation of posterior chordo-papillary apparatus, and group III: included 20 patients who underwent MVR with preservation of both posterior and anterior chordo-papillary apparatus. Results: There were 20 males (33.3%), and the mean age was 48.76± 8.91 years. Patients in group III were significantly older (37.15 ±4.92, 39.8 ± 5.49, and 57.25 ± 6.93 years in groups I, II, and III, respectively; p< 0.001). The left ventricular end-diastolic (5.40 ±0.34, 4.96 ± 0.43, and 4.44 ± 0.55 mm in group I, II and III, respectively, p<0.001) and end-systolic diameter (4.33 ±0.48, 3.58 ±0.43 and 3.20 ±0.43 mm in group I, II and III; respectively, p<0.001) were significantly reduced in partial and complete preservation groups after 6 months. Left ventricular ejection fraction improved in the bilateral preservation and partial preservation groups after 6 months (45.32 ±9.78, 56.79 ±10.14, and 56.60 ±11.68 % in groups I, II and III respectively, p<0.001). Mechanical ventilation was significantly longer in group I (24.10 ± 6.6, 16.80 ± 5.97, and 15.80 ± 5.24 hours in groups I, II and III, respectively, p<0.001) and the duration of ICU stay was significantly longer in group I (78.65 ± 15.32, 65.40 ± 14.21, and 60.20 ± 12.58 hours in groups I, II and III, respectively, p<0.001). Conclusion: Preservation of the annulo-papillary continuity may preserve left ventricular geometry and performance. Total preservation of chordae could be superior to partial preservation with better left ventricular remodeling and improvement in the left ventricular functions.
No takes yet. Share an insight, caveat, or question.
Shalaby et al. (2020) conducted an observational in Mitral valve replacement (n=60). Bilateral or partial chordo-papillary apparatus preservation vs. Complete excision of the subvalvular chordae and tips of papillary muscles was evaluated on Left ventricular ejection fraction at 6 months (p=<0.001). Bilateral and partial chordo-papillary preservation during mitral valve replacement improved left ventricular ejection fraction at 6 months compared to complete excision.
Synapse has enriched 10 related papers. Consider them for comparative context: